| Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored E Mikó, T Kovács, É Sebő, J Tóth, T Csonka, G Ujlaki, A Sipos, J Szabó, ... Cells 8 (4), 293, 2019 | 151 | 2019 |
| Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness E Mikó, A Vida, T Kovács, G Ujlaki, G Trencsényi, J Márton, Z Sári, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 958-974, 2018 | 146 | 2018 |
| Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors T Kovács, E Mikó, A Vida, É Sebő, J Toth, T Csonka, A Boratkó, G Ujlaki, ... Scientific reports 9 (1), 1300, 2019 | 143 | 2019 |
| Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer P Kovács, T Csonka, T Kovács, Z Sári, G Ujlaki, A Sipos, Z Karányi, ... Cancers 11 (9), 1255, 2019 | 79 | 2019 |
| Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress Z Sári, E Mikó, T Kovács, L Jankó, T Csonka, G Lente, É Sebő, J Tóth, ... Cancers 12 (9), 2411, 2020 | 77 | 2020 |
| The microbiome as a component of the tumor microenvironment T Kovács, E Mikó, G Ujlaki, Z Sári, P Bai Tumor Microenvironment: Recent Advances, 137-153, 2020 | 72 | 2020 |
| Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism K Smolková, E Mikó, T Kovács, A Leguina-Ruzzi, A Sipos, P Bai Antioxidants & Redox Signaling 33 (13), 966-997, 2020 | 58 | 2020 |
| Indoxylsulfate, a metabolite of the microbiome, has cytostatic effects in breast cancer via activation of AHR and PXR receptors and induction of oxidative stress Z Sári, E Mikó, T Kovács, A Boratkó, G Ujlaki, L Jankó, B Kiss, K Uray, ... Cancers 12 (10), 2915, 2020 | 37 | 2020 |
| Deletion of poly (ADP‑ribose) polymerase-1 changes the composition of the microbiome in the gut A Vida, G Kardos, T Kovács, BL Bodrogi, P Bai Molecular Medicine Reports 18 (5), 4335-4341, 2018 | 19 | 2018 |
| Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging G Trencsényi, N Dénes, G Nagy, A Kis, A Vida, F Farkas, JP Szabó, ... Journal of pharmaceutical and biomedical analysis 139, 54-64, 2017 | 18 | 2017 |
| In vivo imaging of experimental melanoma tumors using the novel radiotracer 68Ga-NODAGA-procainamide (PCA) I Kertész, A Vida, G Nagy, M Emri, A Farkas, A Kis, J Angyal, N Dénes, ... Journal of Cancer 8 (5), 774, 2017 | 16 | 2017 |
| Silencing of PARP2 blocks autophagic degradation L Jankó, Z Sári, T Kovács, G Kis, M Szántó, M Antal, G Juhász, P Bai Cells 9 (2), 380, 2020 | 12 | 2020 |
| Fecal expression of Escherichia coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma Z Sári, T Kovács, T Csonka, M Török, É Sebő, J Tóth, D Tóth, E Mikó, ... Physiology International 107 (2), 349-358, 2020 | 11 | 2020 |
| Silencing of poly (ADP-ribose) polymerase-2 induces mitochondrial reactive species production and mitochondrial fragmentation L Jankó, T Kovács, M Laczik, Z Sári, G Ujlaki, G Kis, I Horváth, M Antal, ... Cells 10 (6), 1387, 2021 | 6 | 2021 |
| Glycogen phosphorylase inhibitor, 2, 3‐bis [(2E)‐3‐(4‐hydroxyphenyl) prop‐2‐enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells L Nagy, F Béke, L Juhász, T Kovács, É Juhász-Tóth, T Docsa, A Tóth, ... Plos one 15 (9), e0236081, 2020 | 5 | 2020 |
| Methods to assess the role of poly (ADP-ribose) polymerases in regulating mitochondrial oxidation E Mikó, T Kovács, T Fodor, P Bai Poly (ADP-Ribose) Polymerase: Methods and Protocols, 185-200, 2017 | 3 | 2017 |
| 4-chloro-orto-cresol activates ryanodine receptor more selectively and potently than 4-chloro-meta-cresol M Skaliczki, B Lukács, ZÉ Magyar, T Kovács, M Bárdi, S Novák, ... Cell Calcium 88, 102213, 2020 | 1 | 2020 |
Peter BaiProfessor at the University of DebrecenE-mail megerősítve itt: dote.hu
